MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05547cam a2200841Ma 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn785777976 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240925154147.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120227s2012 enka ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
E7B |
| Language of cataloging |
eng |
| Description conventions |
pn |
| Transcribing agency |
E7B |
| Modifying agency |
OCLCQ |
| -- |
YDXCP |
| -- |
CUS |
| -- |
OCLCQ |
| -- |
N$T |
| -- |
IDEBK |
| -- |
CDX |
| -- |
OCLCA |
| -- |
OCLCF |
| -- |
DEBSZ |
| -- |
DA$ |
| -- |
EBLCP |
| -- |
UKDOC |
| -- |
OCLCQ |
| -- |
AGLDB |
| -- |
OCLCQ |
| -- |
STF |
| -- |
VTS |
| -- |
REC |
| -- |
AU@ |
| -- |
OCLCQ |
| -- |
LEAUB |
| -- |
AJS |
| -- |
DKU |
| -- |
OCLCO |
| 019 ## - |
|---|
| -- |
780036541 |
| -- |
858227947 |
| -- |
1086526656 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781848166295 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
184816629X |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
1848166281 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
9781848166288 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
516762 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)785777976 |
| Canceled/invalid control number |
(OCoLC)780036541 |
| -- |
(OCoLC)858227947 |
| -- |
(OCoLC)1086526656 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
QP519.9.I44 |
| Item number |
A68 2012eb |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
071000 |
| Source |
bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.3/7 |
| Edition number |
22 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Antibody drug discovery / |
| Statement of responsibility, etc. |
Clive R. Wood, editor. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
London : |
| Name of publisher, distributor, etc. |
Imperial College Press, |
| Date of publication, distribution, etc. |
2012. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xv, 473 pages) : |
| Other physical details |
illustrations (some color) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
Molecular medicine and medicinal chemistry ; |
| Volume/sequential designation |
v. 4 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Ch. 1. Humanization of antibodies / Olivier Leger and Jose W. Saldanha -- ch. 2. Selection and screening of antibody phage display libraries / David R. Buckler [and others] -- ch. 3. Affinity maturation approaches for antibody lead optimization / David Lowe, Trevor Wilkinson and Tristan J. Vaughan -- ch. 4. Transgenic mice rearranging human antibodies / Sean Stevens -- ch. 5. Isotype selection and Fc engineering: design and construction of fit-for-purpose therapeutic antibodies / William R. Strohl -- ch. 6. Antibody expression from bacteria to transgenic animals / Paul Stephens and Berni M. Sweeney -- ch. 7. Current trends in antibody purification and lead selection / Jie Chen and Andrew Nixon -- ch. 8. Design and application of immunoconjugates for cancer therapy / Sherif El Sheikh [and others] -- ch. 9. Dual-targeting bispecific antibodies as new therapeutic modalities for cancer / Zhenping Zhu -- ch. 10. Antibody fragments and alternate protein scaffolds / Lioudmila Tchistiakova [and others]. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Monoclonal antibodies have become important treatments for cancer, inflammation and a wide range of other diseases, representing an increasing share of the most successful pharmaceutical markets. The technologies to discover these drugs have been developed by select centers of excellence in industry and academia, and are continually being fine tuned in the race to identify the best antibody-based drug candidates and accelerate their paths to patients. The objective of this volume is to provide a series of guides to those evaluating and preparing to enter particular areas within the field and to offer specialized perspectives to established researchers. The chapters set into context the significance of key developments and important considerations for selecting different approaches, such as antibody humanization, isotype selection, lead candidate selection criteria and protein production. All contributors to this work are experts in their fields and many have played pivotal roles in the creation of these technologies. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
WorldCat record variable field(s) change: 650 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunoenzyme technique. |
| 9 (RLIN) |
137117 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antibody-drug conjugates. |
| 9 (RLIN) |
82831 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunology |
| General subdivision |
Technique. |
| 9 (RLIN) |
143808 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug development. |
| 9 (RLIN) |
80817 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical biotechnology. |
| 9 (RLIN) |
86925 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunoglobulins. |
| 9 (RLIN) |
79914 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antibodies |
| 9 (RLIN) |
79912 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunoglobulins |
| 9 (RLIN) |
79914 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Discovery |
| 9 (RLIN) |
84661 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunoenzyme Techniques |
| 9 (RLIN) |
79869 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Serum Globulins |
| 9 (RLIN) |
79916 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Technique immuno-enzymatique. |
| 9 (RLIN) |
137118 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Conjugués anticorps-médicament. |
| 9 (RLIN) |
82835 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunologie |
| General subdivision |
Technique. |
| 9 (RLIN) |
1020491 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Médicaments |
| General subdivision |
Développement. |
| 9 (RLIN) |
105681 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biotechnologie pharmaceutique. |
| 9 (RLIN) |
133789 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Anticorps. |
| 9 (RLIN) |
119387 |
| 650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunoglobulines. |
| 9 (RLIN) |
103712 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL |
| General subdivision |
Pharmacology. |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
80262 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antibody-drug conjugates. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00810453 |
| 9 (RLIN) |
82831 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug development. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00898670 |
| 9 (RLIN) |
80817 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunoenzyme technique. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00967945 |
| 9 (RLIN) |
137117 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Immunology |
| General subdivision |
Technique. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst00968026 |
| 9 (RLIN) |
143808 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical biotechnology. |
| Source of heading or term |
fast |
| Authority record control number |
(OCoLC)fst01060106 |
| 9 (RLIN) |
86925 |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 9 (RLIN) |
396 |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 9 (RLIN) |
396 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wood, Clive R. |
| 9 (RLIN) |
629399 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Print version: |
| Title |
Antibody drug discovery. |
| Place, publisher, and date of publication |
London : Imperial College Press, ©2012 |
| International Standard Book Number |
9781848166288 |
| Record control number |
(OCoLC)776670289 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Molecular medicine and medicinal chemistry ; |
| Volume number/sequential designation |
v. 4. |
| 9 (RLIN) |
583454 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
EBSCOhost |
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=516762">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=516762</a> |
| 938 ## - |
|---|
| -- |
123Library |
| -- |
123L |
| -- |
52486 |
| 938 ## - |
|---|
| -- |
Coutts Information Services |
| -- |
COUT |
| -- |
25731075 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL846126 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10529377 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
516762 |
| 938 ## - |
|---|
| -- |
ProQuest MyiLibrary Digital eBook Collection |
| -- |
IDEB |
| -- |
cis25731075 |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
6989181 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |